Christopher Wong

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

Hypertension, Renal Function, Renal Disease +10

Cyclin-Dependent Kinase (CDK) Inhibitors: Structure–Activity Relationships and Insights into the CDK-2 Selectivity of 6-Substituted 2-Arylaminopurines

Christopher R. Coxon, Elizabeth Anscombe, Suzannah J. Harnor et al. · Journal of Medicinal Chemistry · 2016 · 113 citations · Full text

Macrophage activation syndrome-like (MAS-L) manifestations following BCMA-directed CAR T cells in multiple myeloma

Vanessa E. Kennedy, Christopher Wong, Chiung‐Yu Huang et al. · Blood Advances · 2021 · 50 citations · Full text

Immunodeficiencies, T-regulatory Cell, Immunology +17

Trifluoroacetic Acid in 2,2,2‐Trifluoroethanol Facilitates S_NAr Reactions of Heterocycles with Arylamines

Benoît Carbain, Christopher R. Coxon, Honorine Lebraud et al. · Chemistry - A European Journal · 2014 · 39 citations

MLK3 regulates fMLP-stimulated neutrophil motility

Oksana Polesskaya, Christopher Wong, Luis Lebron et al. · Molecular Immunology · 2014 · 25 citations · Full text

Inflammation, Molecular Physiology, Signal Transduction +7